Clinical Trial - Trial jRCTs031220473
Access comprehensive clinical trial information for jRCTs031220473 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Recruiting. The study focuses on Rheumatoid arthritis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCTs031220473
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCTs031220473
Untitled Trial
Achievement and its clinical significance of molecular remission induced by baricitinib treatment for active rheumatoid arthritis patients with methotrexate inadequate response (RA Be in Remission Study)
Study Focus
Interventional
Sponsor & Location
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Rheumatoid arthritis, unspecified
Other rheumatoid arthritis
Other specified rheumatoid arthritis
Rheumatoid arthritis with involvement of other organs and systems
Seronegative rheumatoid arthritis
Data Source
Japan Registry Clinical Trial
jRCTs031220473
Non-Device Trial